Company / Interest Expense per Share
Sonoma Pharmaceuticals, Inc. Interest Expense per Share History
FY2017-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
-$0.00
FY2023
5-year range
-$0.00 / $0.00
FY2019-FY2023
Trend
-268.7%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share changed -269% YoY in FY2023, a notable deviation from the 6-year average annual change of +1295%.
Based on SEC 10-K filings.
-0.00 in FY2023.
Improved from $0.01 to $-0.00 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Sonoma Pharmaceuticals, Inc.'s interest expense per share has declined for 4 consecutive years.
- In FY2023, interest expense per share decreased 268.7% year-over-year.
- Peak interest expense per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | -$0.00 | -268.7% |
| FY2022 | $0.00 | -78.8% |
| FY2021 | $0.01 | -64.1% |
| FY2020 | $0.03 | -57.0% |
| FY2019 | $0.06 | +8240.0% |
| FY2018 | $0.00 | -2.2% |
| FY2017 | $0.00 | +258.5% |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026